• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种抗真菌剂酮康唑和特比萘芬对人肝微粒体体外代谢甲苯磺丁脲、炔雌醇、环孢素和乙氧香豆素的比较作用。

Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro.

作者信息

Back D J, Stevenson P, Tjia J F

机构信息

Department of Pharmacology and Therapeutics, University of Liverpool.

出版信息

Br J Clin Pharmacol. 1989 Aug;28(2):166-70. doi: 10.1111/j.1365-2125.1989.tb05410.x.

DOI:10.1111/j.1365-2125.1989.tb05410.x
PMID:2775622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1379899/
Abstract

Two antimycotic agents, the azole ketoconazole and the allylamine terbinafine, have been examined for their effects on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes (n = 4) in vitro. Ketoconazole caused marked inhibition of all enzyme activities with mean IC50 values (concentration producing 50% inhibition) of 17.9 microM (tolbutamide hydroxylase), 1.9 microM (ethinyloestradiol 2-hydroxylase), 2.0 microM (cyclosporin N-demethylase), 2.1 microM (cyclosporin hydroxylase) and 25 microM (ethoxycoumarin O-deethylase). At 50 microM terbinafine concentration, inhibition was less than 5% for tolbutamide and ethoxycoumarin, approximately 12% for both cyclosporin pathways and 35% for ethinyloestradiol. Terbinafine does not have the same inhibitory potential for cytochrome P-450 isozymes as ketoconazole.

摘要

研究了两种抗真菌药物,即唑类的酮康唑和烯丙胺类的特比萘芬,在体外对人肝微粒体(n = 4)代谢甲苯磺丁脲、炔雌醇、环孢素和乙氧香豆素的影响。酮康唑对所有酶活性均有显著抑制作用,甲苯磺丁脲羟化酶的平均IC50值(产生50%抑制作用的浓度)为17.9微摩尔/升,炔雌醇2 -羟化酶为1.9微摩尔/升,环孢素N -脱甲基酶为2.0微摩尔/升,环孢素羟化酶为2.1微摩尔/升,乙氧香豆素O -脱乙基酶为25微摩尔/升。在特比萘芬浓度为50微摩尔/升时,对甲苯磺丁脲和乙氧香豆素的抑制作用小于5%,对环孢素的两条代谢途径的抑制作用约为12%,对炔雌醇的抑制作用为35%。特比萘芬对细胞色素P - 450同工酶的抑制潜力与酮康唑不同。

相似文献

1
Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro.两种抗真菌剂酮康唑和特比萘芬对人肝微粒体体外代谢甲苯磺丁脲、炔雌醇、环孢素和乙氧香豆素的比较作用。
Br J Clin Pharmacol. 1989 Aug;28(2):166-70. doi: 10.1111/j.1365-2125.1989.tb05410.x.
2
Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.抗真菌药物酮康唑、氟康唑、伊曲康唑和特比萘芬对人肝微粒体中环孢素代谢的比较效应。
Br J Clin Pharmacol. 1991 Nov;32(5):624-6. doi: 10.1111/j.1365-2125.1991.tb03963.x.
3
Azoles, allylamines and drug metabolism.唑类、烯丙胺类与药物代谢。
Br J Dermatol. 1992 Feb;126 Suppl 39:14-8. doi: 10.1111/j.1365-2133.1992.tb00003.x.
4
Tolbutamide 4-hydroxylase activity of human liver microsomes: effect of inhibitors.人肝微粒体甲苯磺丁脲4-羟化酶活性:抑制剂的影响。
Br J Clin Pharmacol. 1987 Aug;24(2):230-4. doi: 10.1111/j.1365-2125.1987.tb03167.x.
5
In vitro characterization of the inhibitory effects of ketoconazole on metabolic activities of cytochrome P-450 in canine hepatic microsomes.酮康唑对犬肝微粒体细胞色素P-450代谢活性抑制作用的体外特性研究
Am J Vet Res. 2002 Jun;63(6):900-5. doi: 10.2460/ajvr.2002.63.900.
6
In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines.唑类、磺胺类和喹啉类药物对人肝微粒体甲苯磺丁脲羟化酶活性的体外抑制研究。
Br J Clin Pharmacol. 1988 Jul;26(1):23-9. doi: 10.1111/j.1365-2125.1988.tb03359.x.
7
Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9.酮康唑和磺胺苯唑分别作为细胞色素P450 3A和2C9的选择性抑制剂。
Xenobiotica. 1995 Mar;25(3):261-70. doi: 10.3109/00498259509061850.
8
The effects of retinoids and terbinafine on the human hepatic microsomal metabolism of cyclosporin.维甲酸和特比萘芬对环孢素在人肝微粒体代谢中的影响。
Br J Dermatol. 1993 Oct;129(4):395-8. doi: 10.1111/j.1365-2133.1993.tb03164.x.
9
The antimycotic drug terbinafine in contrast to ketoconazole lacks acute effects on the pituitary-testicular function of healthy men: a placebo-controlled double-blind trial.与酮康唑相比,抗真菌药物特比萘芬对健康男性的垂体-睾丸功能缺乏急性影响:一项安慰剂对照双盲试验。
Acta Endocrinol (Copenh). 1989 May;120(5):677-81. doi: 10.1530/acta.0.1200677.
10
Comparison of two azole antifungal drugs, ketoconazole, and fluconazole, as modifiers of rat hepatic monooxygenase activity.两种唑类抗真菌药物酮康唑和氟康唑作为大鼠肝脏单加氧酶活性调节剂的比较。
Biochem Pharmacol. 1988 Feb 1;37(3):401-8. doi: 10.1016/0006-2952(88)90206-7.

引用本文的文献

1
Update on terbinafine with a focus on dermatophytoses.特比萘芬更新:重点关注皮肤癣菌病。
Clin Cosmet Investig Dermatol. 2009 Apr 21;2:49-63. doi: 10.2147/ccid.s3690.
2
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.重症监护病房感染治疗的药代动力学方面:聚焦于药物相互作用。
Clin Pharmacokinet. 2001;40(11):833-68. doi: 10.2165/00003088-200140110-00004.
3
Identification of the cytochrome P450 enzymes involved in the metabolism of cisapride: in vitro studies of potential co-medication interactions.鉴定参与西沙必利代谢的细胞色素P450酶:潜在联合用药相互作用的体外研究
Br J Pharmacol. 2000 Apr;129(8):1655-67. doi: 10.1038/sj.bjp.0703246.
4
A further interaction study of quinine with clinically important drugs by human liver microsomes: determinations of inhibition constant (Ki) and type of inhibition.奎宁与临床重要药物在人肝微粒体中的进一步相互作用研究:抑制常数(Ki)的测定及抑制类型
Eur J Drug Metab Pharmacokinet. 1999 Jul-Sep;24(3):272-8. doi: 10.1007/BF03190031.
5
Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.抗真菌药物对氧化药物代谢的影响:临床相关性。
Clin Pharmacokinet. 2000 Feb;38(2):111-80. doi: 10.2165/00003088-200038020-00002.
6
Microsomal prediction of in vivo clearance of CYP2C9 substrates in humans.人体中CYP2C9底物体内清除率的微粒体预测
Br J Clin Pharmacol. 1999 Jun;47(6):625-35. doi: 10.1046/j.1365-2125.1999.00935.x.
7
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism.细胞色素P4502C9:人类药物代谢中至关重要的一种酶。
Br J Clin Pharmacol. 1998 Jun;45(6):525-38. doi: 10.1046/j.1365-2125.1998.00721.x.
8
Systemic antifungal agents. Drug interactions of clinical significance.全身性抗真菌药物。具有临床意义的药物相互作用。
Drug Saf. 1998 Feb;18(2):83-97. doi: 10.2165/00002018-199818020-00001.
9
Pharmacokinetic optimisation of oral antifungal therapy.口服抗真菌治疗的药代动力学优化
Clin Pharmacokinet. 1993 Oct;25(4):329-41. doi: 10.2165/00003088-199325040-00006.
10
Generation of oxygen free radicals during the metabolism of cyclosporine A: a cause-effect relationship with metabolism inhibition.环孢素A代谢过程中氧自由基的产生:与代谢抑制的因果关系
Mol Cell Biochem. 1993 May 26;122(2):101-12. doi: 10.1007/BF01076094.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.肝微粒体的一氧化碳结合色素。I. 其血红蛋白性质的证据。
J Biol Chem. 1964 Jul;239:2370-8.
3
Characterization of three highly purified cytochromes P-450 from hepatic microsomes of adult male rats.成年雄性大鼠肝微粒体中三种高度纯化的细胞色素P-450的特性分析。
J Biol Chem. 1984 Jan 25;259(2):1239-50.
4
In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis.抗真菌药物酮康唑对甾醇合成的体外和体内作用。
Antimicrob Agents Chemother. 1980 Jun;17(6):922-8. doi: 10.1128/AAC.17.6.922.
5
Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver.酮康唑:大鼠肝脏中细胞色素P - 450依赖性药物代谢的强效抑制剂。
Drug Metab Dispos. 1984 Sep-Oct;12(5):603-6.
6
Ketoconazole and cyclosporin.
Lancet. 1982 Nov 27;2(8309):1217. doi: 10.1016/s0140-6736(82)91231-4.
7
Ketoconazole, cyclosporin metabolism, and renal transplantation.
Lancet. 1982 Oct 16;2(8303):882-3. doi: 10.1016/s0140-6736(82)90851-0.
8
The interaction of representative members from two classes of antimycotics--the azoles and the allylamines--with cytochromes P-450 in steroidogenic tissues and liver.
Xenobiotica. 1985 Jun;15(6):529-46. doi: 10.3109/00498258509045027.
9
Inhibition of tolbutamide metabolism by substituted imidazole drugs in vivo: evidence for a structure-activity relationship.体内取代咪唑类药物对甲苯磺丁脲代谢的抑制作用:构效关系的证据。
Br J Pharmacol. 1985 May;85(1):121-6. doi: 10.1111/j.1476-5381.1985.tb08838.x.
10
Effect of ketoconazole on hepatic oxidative drug metabolism.酮康唑对肝脏氧化药物代谢的影响。
Clin Pharmacol Ther. 1985 Mar;37(3):290-7. doi: 10.1038/clpt.1985.42.